PATH | VRL
Menu

A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis

This article, published in Advances in Therapy, reviews the impacts of 7-valent pneumococcal polysaccharide conjugate vaccine (PCV7) on pneumococcal meningitis. The authors conclude that the results show PCV7 to have significant impact on pneumococcal meningitis across all ages through pediatric immunization programs. They emphasize the importance of robust surveillance systems to continue to monitor pneumococcal meningitis following the introduction of 13-valent PCV. ABSTRACT ONLY: (Learn how users in developing countries can gain free access to journal articles.)

Author: Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E

Published: 2013

» Visit web page (English)

(Located at www.advancesintherapy.com)

Citation. Tin Tin Htar M, Madhava H, Balmer P, Christopoulou D, Menegas D, Bonnet E. A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis. Advances in Therapy. 2013;30(8):748-762.

Resource types: Peer-reviewed journal

Diseases/vaccines: Meningococcus, Pneumococcus

Topics: Disease/vaccine specific information

Regions: Global